Jennison Associates LLC Biolife Solutions Inc Transaction History

Jennison Associates LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$8.99 - $16.86 $3.28 Million - $6.14 Million	-364,461 Reduced 90.12%	39,978 $649,000
Q3 2023 Oct 31, 2023	SELL	$10.81 - $22.96 $3.26 Million - $6.93 Million	-301,681 Reduced 42.72%	404,439 $5.59 Million
Q2 2023 Aug 03, 2023	SELL	$17.19 - $24.34 $3.77 Million - $5.34 Million	-219,261 Reduced 23.69%	706,120 $15.6 Million
Q1 2023 Apr 26, 2023	SELL	$17.67 - $26.07 $1.2 Million - $1.77 Million	-67,858 Reduced 6.83%	925,381 $20.1 Million
Q4 2022 Feb 09, 2023	BUY	$16.95 - $25.07 $6.61 Million - $9.77 Million	389,812 Added 64.6%	993,239 $18.1 Million
Q3 2022 Nov 01, 2022	BUY	$14.64 - $26.7 $2.16 Million - $3.93 Million	147,324 Added 32.3%	603,427 $13.7 Million
Q2 2022 Aug 02, 2022	BUY	$10.54 - $24.2 $355,840 - $817,016	33,761 Added 7.99%	456,103 $6.3 Million
Q1 2022 May 11, 2022	SELL	$20.81 - $37.29 $8.66 Million - $15.5 Million	-415,907 Reduced 49.62%	422,342 $9.6 Million
Q4 2021 Feb 08, 2022	BUY	$32.99 - $58.55 $17.9 Million - $31.8 Million	543,914 Added 184.79%	838,249 $31.2 Million
Q3 2021 Nov 09, 2021	SELL	$42.03 - $60.5 $421,266 - $606,391	-10,023 Reduced 3.29%	294,335 $12.5 Million
Q2 2021 Aug 12, 2021	SELL	$29.51 - $44.62 $174,109 - $263,258	-5,900 Reduced 1.9%	304,358 $13.5 Million
Q1 2021 May 11, 2021	SELL	$32.95 - $44.24 $4.59 Million - $6.16 Million	-139,316 Reduced 30.99%	310,258 $11.2 Million
Q4 2020 Feb 05, 2021	BUY	$27.5 - $45.75 $12.4 Million - $20.6 Million	449,574 New	449,574 $17.9 Million

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.